This article is a retraction of:
RETRACTED: Icariin Reduces Dopaminergic Neuronal Loss and Microglia-Mediated Inflammation in Vivo and in Vitro
Frontiers Editorial OfficeA Retraction of the Original Research Article
Icariin reduces dopaminergic neuronal loss and microglia-mediated inflammation in vivo and in vitro
by Wang G-Q, Li D-D, Huang C, Lu D-S, Zhang C, Zhou S-Y, Liu J and Zhang F (2018). Front. Mol. Neurosci. 10:441. doi: 10.3389/fnmol.2017.00441
Please find the retraction statement below:
Following publication, concerns were raised regarding the scientific validity of the article. An investigation was conducted in accordance with Frontiers' policies. It was found that the complaints were valid and that the article does not meet the standards of editorial and scientific soundness for Frontiers in Molecular Neuroscience; therefore, the article has been retracted.
This retraction was approved by the Chief Editors of Frontiers in Molecular Neuroscience and the Chief Executive Editor of Frontiers. The authors do not agree to this retraction.
Citation: Frontiers Editorial Office (2024) Retraction: Icariin reduces dopaminergic neuronal loss and microglia-mediated inflammation in vivo and in vitro. Front. Mol. Neurosci. 17:1441744. doi: 10.3389/fnmol.2024.1441744
Received: 31 May 2024; Accepted: 31 May 2024;
Published: 20 June 2024.
Approved by:
Jean-Marc Taymans, Institut National de la Santé et de la Recherche Médicale (INSERM), FranceCopyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org